Indeed, the complex interaction between environmental and genetic risk factors might worsen the health complications of DM (206, 211)
[END CALLOUT BOX] GLP2 Research Applications & Key Findings Type 2 Diabetes Management SURPASS Clinical Trial Program The SURPASS phase 3 clinical program enrolled over 6,000 participants across five global registration trials, evaluating GLP2 across the type 2 diabetes treatment continuum
If prescribed, a provider will be just a message away for follow-ups, adjustments, and ongoing support
Protect it from light by storing it in its original packaging
Pricing, guarantee terms, medical group affiliations, pharmacy partners, and service availability may change after publication